The recent advances in nuclear medicine like radiopharmaceuticals and equipments have gained popularity owing to their greater application in multimodality imaging. However, among many positron emission tomography (PET) radiopharmaceuticals, one is most widely applied in clinical practice and has obtained FDA approval for its application in epileptic foci identification and mapping of tumor metabolism. Can you name it?
Here is an interesting activity to refresh your knowledge of radiopharmaceuticals. Attempt this question! Source: The British Institute of Radiology
